Woodford Patient Capital Trust’s holdings in companies in which its independent directors, including its chairwoman, hold senior positions has raised eyebrows with investors, as they highlight concerns about the board’s ability to act in shareholders’ best interests.
Unicorn Asset Management’s Simon Moon and Fraser Mackersie have apologised to investors in the Acorn Income fund for holding Coviviality as it went under.
Neil Woodford has highlighted his track record for backing biotech winners in his Patient Capital Trust annual review, just one day after Prothena’s share price blow-up.
Invesco has announced it is stepping down as investment manager on the Invesco Perpetual Enhanced Income trust, in a shock move that is being put down to a clash with the board over performance fees.
Fidelity Asian Values has become the second investment trust run by the firm to adopt a variable management fee model.
Woodford Investment Management has admitted it failed to disclose increases to its Raven Russia holding made over the last year, as it continues to add to the investment company in the wake of US sanctions.
The JP Morgan Emerging Markets Investment Trust has been touted as a stable alternative to Templeton Emerging Markets Investment Trust, where careful succession planning following Mark Mobius’s retirement was thrown into disarray with the sudden departure of his replacement Carlos Hardenberg earlier this year.
Infrastructure delivered some of the worst performers among investment trusts in Q1 on the back of Carillion’s collapse and fears in the UK of a Labour-led government, while Donald Trump is getting the blame for falls in US investment trusts as well as biotechnology portfolios. Portfolio Advisers looks at the 10 investment trusts that fared…
The Blackrock Smaller Companies Trust is ditching performance fees in an effort to stay competitive with rival investment trusts.
The Association of Investment Companies (AIC) has appointed alternatives expert Susie Farnon to its board of directors.
A short position in Conviviality has delivered for Blackrock Throgmorton, according to its first portfolio update since investors voted in favour of expanding the portfolio’s investment universe.
The board of the Schroder UK Growth fund is dumping Schroders as its manager and replacing it with Baillie Gifford, citing continuous underperformance since inception as the reason behind the decision.
